CA
CANL.US Cannlabs Inc
- Market cap
- USD 46.3K
- P/E
- -
- P/B
- 25.22x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2023.
Is CANL.US undervalued?
Graham numberThe Graham number of Cannlabs Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Cannlabs Inc fundamental analysis
No fundamental analysis for Cannlabs Inc yet.
Cannlabs Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Cannlabs Inc
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 an…
Full company profileCannlabs Inc financial statements
2023 annualized: Fiscal year 2023 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2023, the balance sheet is the latest quarter. Figures change when the annual report is published.
Cannlabs Inc annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2012 | 2013 | 2014 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 146K | 84.3K | 1.36M | 1.36M | 1.36M | 1.36M | 2.50M | 2.77M | 3.18M | 4.39M | - |
| Gross Profit | 146K | 84.2K | 478K | -1.26M | 478K | 478K | 1.45M | 1.25M | 1.70M | 2.06M | - |
| Operating Income | -26.5K | -77.8K | -3.19M | -3.19M | -3.19M | -3.19M | 804K | 522K | 714K | 872K | - |
| EBITDA | 5.53K | -57.4K | -2.96M | -2.96M | -2.96M | -2.96M | 811K | 531K | 723K | 881K | - |
| Net Income | -27.8K | -79.0K | -1.58M | -1.58M | -1.58M | -1.58M | 804K | 521K | 713K | 869K | - |
| EPS | 0.00 | 0.00 | -0.03 | -0.03 | -0.03 | -0.03 | 0.01 | 0.00 | 0.00 | 0.00 | - |
| Balance Sheet | |||||||||||
| Total Assets | 32.0K | 210K | 1.32M | 1.32M | 1.32M | 1.32M | 2.19M | 2.70M | 2.98M | 3.25M | - |
| Total Liabilities | 29.9K | 106K | 2.95M | 2.95M | 2.95M | 2.95M | 325K | 783K | 789K | 846K | - |
| Shareholders' Equity | 2.05K | 104K | 790.00 | 790.00 | 790.00 | 790.00 | 1.86M | 1.92M | 2.19M | 2.40M | - |
| Cash & Short-term Investments | 0.00 | 33.2K | 11.3K | 11.3K | 11.3K | 11.3K | 353K | 499K | 538K | 651K | - |
| Total Debt | 11.2K | 8.25K | 1.89M | 1.89M | 1.89M | 1.89M | - | - | - | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | -56.2K | -50.9K | -1.26M | -1.26M | -1.26M | -1.26M | 551K | 571K | 533K | 773K | - |
| Capital Expenditure | 70.4K | 70.40 | 360K | 360K | 360K | 360K | 0.00 | 3.00 | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -56.2K | -51.0K | -1.62M | -1.62M | -1.62M | -1.62M | 551K | 571K | 533K | 773K | - |
| Ratios | |||||||||||
| ROE | -1,352.2% | -75.7% | -200,533.9% | -200,533.9% | -200,533.9% | -200,533.9% | 43.1% | 27.1% | 32.5% | 36.2% | - |
| ROA | -86.8% | -37.7% | -120.2% | -120.2% | -120.2% | -120.2% | 36.7% | 19.3% | 23.9% | 26.8% | - |
| Net Profit Margin | -19.0% | -93.7% | -116.1% | -116.1% | -116.1% | -116.1% | 32.2% | 18.8% | 22.4% | 19.8% | - |
| Debt to Equity | 5.47x | 0.08x | 2,397.56x | 2,397.56x | 2,397.56x | 2,397.56x | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Cannlabs Inc dividends
Cannlabs Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 7:1 on Jun 12, 2014.
Who owns Cannlabs Inc
Ownership data of Cannlabs Inc is not available yet.
Cannlabs Inc company profile
- Company name
- Cannlabs Inc
- Ticker
- CANL.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Providers & Services
- Employees
- 37
- Fiscal year end
- December
- Address
- 3888 East Mexico Avenue, Denver, CO, United States, 80210
- Phone
- 303-309-0105
- Website
- -
About Cannlabs Inc
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 and is based in Denver, Colorado.
Cannlabs Inc management
1- Mr. Mark C. MirkenChairman & CEO · born 1945